Data protection Impressum

Financing

HemostOD has been awarded a CHF 2 million Innosuisse grant to support the preclinical development of its donor-free, off-the-shelf human blood platelets for transfusion.

HemostOD secures CHF 2 million to advance donor-free platelet development

9 February 2026

Swiss start-ups raised CHF 2.9 billion in 2025, marking a strong recovery in venture capital investment led by ICT and biotech.

Swiss start-ups attract CHF 2.9 billion in 2025 as venture capital rebounds

3 February 2026

SamanTree Medical has secured EUR 20 million from the European Investment Bank to expand its surgical imaging technology across Europe and the United States and accelerate product development.

SamanTree Medical secures EUR 20 million to scale surgical imaging technology

2 February 2026

ORamaVR has raised USD 4.5 million in late-seed funding to accelerate the commercial rollout of its AI-powered medical extended reality platform for surgical training and device simulation.

Geneva-based ORamaVR raises USD 4.5 million to scale medical XR training solutions

30 January 2026

Top Stories Western Switzerland

Top Stories from Western Switzerland (January 2026)

30 January 2026

SWISSto12 has secured EUR 73 million in funding from ESA member states to accelerate the development and industrialization of HummingSat, its next-generation compact geostationary satellite platform.

SWISSto12 secures EUR 73 million ESA backing for HummingSat satellite platform

29 January 2026

Sportswear start-up Revario has reached CHF 1 million in sales, marking a key milestone as it prepares to expand beyond Suisse Romande into new Swiss and European markets.

Fribourg-based Revario reaches CHF 1 million turnover milestone

28 January 2026

Ex Nunc Intelligence has secured USD 2.15 million in pre-seed funding to accelerate the development of its legal intelligence infrastructure, supporting reliable, traceable and confidential AI tools for legal professionals.

Ex Nunc Intelligence raises USD 2.15 million to develop trusted legal AI infrastructure

20 January 2026

Geneva-based biotech start-up FluoSphera has raised CHF 1.15 million to expand its human-relevant preclinical testing platform, supporting the shift toward more predictive and non-animal drug development models.

FluoSphera raises CHF 1.15 million to scale human-based preclinical drug testing

19 January 2026

Top Stories Western Switzerland

Top Stories from Western Switzerland (December 2025)

24 December 2025

1 2 3 4 5 … 38